Drug intelligence / Profile preview

MK-0759

Development stage: Discontinued
Lead developer: Merck

Overview

MK-0759 is an investigational drug candidate developed by Merck. There is no publicly available information in the provided search results or major clinical trial registries about its mechanism of action, therapeutic indication, modality, or development status. No evidence was found that it has reached clinical trials or been marketed under any other name.

Beyond the preview

Go deeper on MK-0759.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MK-0759.

Explore the full profile